{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:41:30Z","timestamp":1791726090485,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13046-014-0103-8","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T17:29:13Z","timestamp":1417627753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Blockade of CXCL12\/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway"],"prefix":"10.1186","volume":"33","author":[{"given":"Shengqiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"103_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000335164","volume":"79","author":"M Higashi","year":"2012","unstructured":"Higashi M, Yamada N, Yokoyama S, Kitamoto S, Tabata K, Koriyama C, Batra SK, Yonezawa S: Pathobiological implications of MUC16\/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. Pathobiology. 2012, 79: 101-106. 10.1159\/000335164.","journal-title":"Pathobiology"},{"key":"103_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1046\/j.1440-1746.2002.02780.x","volume":"17","author":"K Okuda","year":"2002","unstructured":"Okuda K, Nakanuma Y, Miyazaki M: Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment. J Gastroenterol Hepatol. 2002, 17: 1056-1063. 10.1046\/j.1440-1746.2002.02780.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"103_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1046\/j.1440-1746.2002.02781.x","volume":"17","author":"K Okuda","year":"2002","unstructured":"Okuda K, Nakanuma Y, Miyazaki M: Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol. 2002, 17: 1049-1055. 10.1046\/j.1440-1746.2002.02781.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"103_CR4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3892\/ol.2013.1587","volume":"6","author":"K Leelawat","year":"2013","unstructured":"Leelawat K, Keeratichamroen S, Leelawat S, Tohtong R: CD24 induces the invasion of cholangiocarcinoma cells by upregulating CXCR4 and increasing the phosphorylation of ERK1\/2. Oncol Lett. 2013, 6: 1439-1446.","journal-title":"Oncol Lett"},{"key":"103_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2012.02.035","volume":"322","author":"X Li","year":"2012","unstructured":"Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W, Bhat K, Wang F, Wu E, Wang Z: SDF-1\/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett. 2012, 322: 169-176. 10.1016\/j.canlet.2012.02.035.","journal-title":"Cancer Lett"},{"key":"103_CR6","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.celrep.2013.11.001","volume":"5","author":"JD Holland","year":"2013","unstructured":"Holland JD, Gyorffy B, Vogel R, Eckert K, Valenti G, Fang L, Lohneis P, Elezkurtaj S, Ziebold U, Birchmeier W: Combined Wnt\/beta-catenin, Met, and CXCL12\/CXCR4 signals characterize basal breast cancer and predict disease outcome. Cell Rep. 2013, 5: 1214-1227. 10.1016\/j.celrep.2013.11.001.","journal-title":"Cell Rep"},{"key":"103_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0014-5793(98)00359-7","volume":"426","author":"A Caruz","year":"1998","unstructured":"Caruz A, Samsom M, Alonso JM, Alcami J, Baleux F, Virelizier JL, Parmentier M, Arenzana-Seisdedos F: Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett. 1998, 426: 271-278. 10.1016\/S0014-5793(98)00359-7.","journal-title":"FEBS Lett"},{"key":"103_CR8","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.272.5263.872","volume":"272","author":"Y Feng","year":"1996","unstructured":"Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996, 272: 872-877. 10.1126\/science.272.5263.872.","journal-title":"Science"},{"key":"103_CR9","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/cncr.22706","volume":"109","author":"PA Ruffini","year":"2007","unstructured":"Ruffini PA, Morandi P, Cabioglu N, Altundag K, Cristofanilli M: Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer. 2007, 109: 2392-2404. 10.1002\/cncr.22706.","journal-title":"Cancer"},{"key":"103_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill F: Cancer and the chemokine network. Nat Rev Cancer. 2004, 4: 540-550. 10.1038\/nrc1388.","journal-title":"Nat Rev Cancer"},{"key":"103_CR11","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","volume":"107","author":"JA Burger","year":"2006","unstructured":"Burger JA, Kipps TJ: CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood. 2006, 107: 1761-1767. 10.1182\/blood-2005-08-3182.","journal-title":"Blood"},{"key":"103_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","volume":"49","author":"UM Domanska","year":"2013","unstructured":"Domanska UM, Kruizinga RC, Nagengast WB, Timmer-Bosscha H, Huls G, de Vries EG, Walenkamp AM: A review on CXCR4\/CXCL12 axis in oncology: no place to hide. Eur J Cancer. 2013, 49: 219-230. 10.1016\/j.ejca.2012.05.005.","journal-title":"Eur J Cancer"},{"key":"103_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1210\/me.2002-0438","volume":"17","author":"JM Hall","year":"2003","unstructured":"Hall JM, Korach KS: Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol. 2003, 17: 792-803. 10.1210\/me.2002-0438.","journal-title":"Mol Endocrinol"},{"key":"103_CR14","first-page":"1832","volume":"62","author":"RS Taichman","year":"2002","unstructured":"Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK: Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002, 62: 1832-1837.","journal-title":"Cancer Res"},{"key":"103_CR15","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/jnci\/dji431","volume":"97","author":"JT Kaifi","year":"2005","unstructured":"Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P, Heinecke A, Pantel K, Izbicki JR: Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst. 2005, 97: 1840-1847. 10.1093\/jnci\/dji431.","journal-title":"J Natl Cancer Inst"},{"key":"103_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10585-007-9133-3","volume":"25","author":"SY Kim","year":"2008","unstructured":"Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH, Ren L, Wong D, Korz W, Merzouk A, Salari H, Zhang H, Hwang ST, Khanna C, Helman LJ: Inhibition of the CXCR4\/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis. 2008, 25: 201-211. 10.1007\/s10585-007-9133-3.","journal-title":"Clin Exp Metastasis"},{"key":"103_CR17","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3892\/ol.2014.2028","volume":"7","author":"J Sun","year":"2014","unstructured":"Sun J, Feng C, Liao W, Zhang H, Tang S: Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy. Oncol Lett. 2014, 7: 2083-2088.","journal-title":"Oncol Lett"},{"key":"103_CR18","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.4049\/jimmunol.165.8.4372","volume":"165","author":"IJ Crane","year":"2000","unstructured":"Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV: CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1 alpha. J Immunol. 2000, 165: 4372-4378. 10.4049\/jimmunol.165.8.4372.","journal-title":"J Immunol"},{"key":"103_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell. 2005, 121: 335-348. 10.1016\/j.cell.2005.02.034.","journal-title":"Cell"},{"key":"103_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/leu.2008.299","volume":"23","author":"JA Burger","year":"2009","unstructured":"Burger JA, Peled A: CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia. 2009, 23: 43-52. 10.1038\/leu.2008.299.","journal-title":"Leukemia"},{"key":"103_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410: 50-56. 10.1038\/35065016.","journal-title":"Nature"},{"key":"103_CR22","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1038\/onc.2013.448","volume":"33","author":"T Yu","year":"2014","unstructured":"Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z: MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt\/beta-catenin signaling pathway. Oncogene. 2014, 33: 5017-5027. 10.1038\/onc.2013.448.","journal-title":"Oncogene"},{"issue":"10","key":"103_CR23","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/sj.bjc.6604745","volume":"99","author":"Z Wang","year":"2008","unstructured":"Wang Z, Ma Q, Liu Q, Yu H, Zhao L, Shen S, Yao J: Blockade of SDF-1\/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway. Br J Cancer. 2008, 99 (10): 1695-1703. 10.1038\/sj.bjc.6604745.","journal-title":"Br J Cancer"},{"key":"103_CR24","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1038\/onc.2013.448","volume":"33","author":"T Yu","year":"2014","unstructured":"Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z: MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt\/beta-catenin signaling pathway. Oncogene. 2014, 33: 5017-5027. 10.1038\/onc.2013.448.","journal-title":"Oncogene"},{"key":"103_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.canlet.2014.08.012","volume":"354","author":"TH Hu","year":"2014","unstructured":"Hu TH, Yao Y, Yu S, Han LL, Wang WJ, Guo H, Tian T, Ruan ZP, Kang XM, Wang J, Wang SH, Nan KJ: SDF-1\/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt\/beta-catenin signaling pathway. Cancer Lett. 2014, 354: 417-426. 10.1016\/j.canlet.2014.08.012.","journal-title":"Cancer Lett"},{"key":"103_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/IGC.0b013e31821d2543","volume":"21","author":"J Wang","year":"2011","unstructured":"Wang J, Cai J, Han F, Yang C, Tong Q, Cao T, Wu L, Wang Z: Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway. Int J Gynecol Cancer. 2011, 21: 981-987. 10.1097\/IGC.0b013e31821d2543.","journal-title":"Int J Gynecol Cancer"},{"key":"103_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.biocel.2011.01.021","volume":"43","author":"M Tamura","year":"2011","unstructured":"Tamura M, Sato MM, Nashimoto M: Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells. Int J Biochem Cell Biol. 2011, 43: 760-767. 10.1016\/j.biocel.2011.01.021.","journal-title":"Int J Biochem Cell Biol"},{"key":"103_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2353\/ajpath.2006.050204","volume":"168","author":"S Ohira","year":"2006","unstructured":"Ohira S, Sasaki M, Harada K, Sato Y, Zen Y, Isse K, Kozaka K, Ishikawa A, Oda K, Nimura Y, Nakanuma Y: Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma. Am J Pathol. 2006, 168: 1155-1168. 10.2353\/ajpath.2006.050204.","journal-title":"Am J Pathol"},{"key":"103_CR29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jhep.2012.06.012","volume":"57","author":"A Gentilini","year":"2012","unstructured":"Gentilini A, Rombouts K, Galastri S, Caligiuri A, Mingarelli E, Mello T, Marra F, Mantero S, Roncalli M, Invernizzi P, Pinzani M: Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. J Hepatol. 2012, 57: 813-820. 10.1016\/j.jhep.2012.06.012.","journal-title":"J Hepatol"},{"key":"103_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5009\/gnl.2014.8.2.196","volume":"8","author":"XY Tan","year":"2014","unstructured":"Tan XY, Chang S, Liu W, Tang HH: Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma. Gut Liver. 2014, 8: 196-204. 10.5009\/gnl.2014.8.2.196.","journal-title":"Gut Liver"},{"key":"103_CR31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3892\/ijo.2012.1499","volume":"41","author":"K Okamoto","year":"2012","unstructured":"Okamoto K, Tajima H, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Harada S, Wakayama T, Iseki S, Ohta T: Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1\/CXCR4 axis in intrahepatic cholangiocarcinoma. Int J Oncol. 2012, 41: 573-582.","journal-title":"Int J Oncol"},{"key":"103_CR32","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1096\/fj.13-248401","volume":"28","author":"S Zhao","year":"2014","unstructured":"Zhao S, Zhou L, Niu G, Li Y, Zhao D, Zeng H: Differential regulation of orphan nuclear receptor TR3 transcript variants by novel vascular growth factor signaling pathways. FASEB J. 2014, 28: 4524-4533. 10.1096\/fj.13-248401.","journal-title":"FASEB J"},{"key":"103_CR33","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1073\/pnas.2235846100","volume":"100","author":"JB Rubin","year":"2003","unstructured":"Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA: A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A. 2003, 100: 13513-13518. 10.1073\/pnas.2235846100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"103_CR34","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1158\/0008-5472.CAN-04-1844","volume":"64","author":"MC Smith","year":"2004","unstructured":"Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD: CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 2004, 64: 8604-8612. 10.1158\/0008-5472.CAN-04-1844.","journal-title":"Cancer Res"},{"key":"103_CR35","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.1158\/0008-5472.CAN-07-0899","volume":"67","author":"V De Falco","year":"2007","unstructured":"De Falco V, Guarino V, Avilla E, Castellone MD, Salerno P, Salvatore G, Faviana P, Basolo F, Santoro M, Melillo RM: Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer Res. 2007, 67: 11821-11829. 10.1158\/0008-5472.CAN-07-0899.","journal-title":"Cancer Res"},{"key":"103_CR36","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/pros.21008","volume":"69","author":"S Porvasnik","year":"2009","unstructured":"Porvasnik S, Sakamoto N, Kusmartsev S, Eruslanov E, Kim WJ, Cao W, Urbanek C, Wong D, Goodison S, Rosser CJ: Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth. Prostate. 2009, 69: 1460-1469. 10.1002\/pros.21008.","journal-title":"Prostate"},{"key":"103_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/ijc.25665","volume":"129","author":"S Hassan","year":"2011","unstructured":"Hassan S, Buchanan M, Jahan K, Aguilar-Mahecha A, Gaboury L, Muller WJ, Alsawafi Y, Mourskaia AA, Siegel PM, Salvucci O, Basik M: CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Int J Cancer. 2011, 129: 225-232. 10.1002\/ijc.25665.","journal-title":"Int J Cancer"},{"key":"103_CR38","first-page":"3833","volume":"63","author":"IS Zeelenberg","year":"2003","unstructured":"Zeelenberg IS, Ruuls-Van Stalle L, Roos E: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 2003, 63: 3833-3839.","journal-title":"Cancer Res"},{"key":"103_CR39","first-page":"5002","volume":"59","author":"AF Olumi","year":"1999","unstructured":"Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59: 5002-5011.","journal-title":"Cancer Res"},{"key":"103_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1200\/JCO.2010.31.0904","volume":"29","author":"MY Konopleva","year":"2011","unstructured":"Konopleva MY, Jordan CT: Leukemia stem cells and microenvironment: biology and therapeutic targeting. J Clin Oncol. 2011, 29: 591-599. 10.1200\/JCO.2010.31.0904.","journal-title":"J Clin Oncol"},{"key":"103_CR41","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","volume":"113","author":"B Nervi","year":"2009","unstructured":"Nervi B, Ramirez P, Rettig MP, Uy GL, Holt MS, Ritchey JK, Prior JL, Piwnica-Worms D, Bridger G, Ley TJ, DiPersio JF: Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood. 2009, 113: 6206-6214. 10.1182\/blood-2008-06-162123.","journal-title":"Blood"},{"key":"103_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2407-14-49","volume":"14","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Ni C, Chen W, Wu P, Wang Z, Yin J, Huang J, Qiu F: Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis. BMC Cancer. 2014, 14: 49-10.1186\/1471-2407-14-49.","journal-title":"BMC Cancer"},{"key":"103_CR43","doi-asserted-by":"publisher","first-page":"e92629","DOI":"10.1371\/journal.pone.0092629","volume":"9","author":"CF Liu","year":"2014","unstructured":"Liu CF, Liu SY, Min XY, Ji YY, Wang N, Liu D, Ma N, Li ZF, Li K: The prognostic value of CXCR4 in ovarian cancer: a meta-analysis. PLoS One. 2014, 9: e92629-10.1371\/journal.pone.0092629.","journal-title":"PLoS One"},{"key":"103_CR44","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1158\/0008-5472.CAN-05-0847","volume":"65","author":"BM Woerner","year":"2005","unstructured":"Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB: Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. Cancer Res. 2005, 65: 11392-11399. 10.1158\/0008-5472.CAN-05-0847.","journal-title":"Cancer Res"},{"key":"103_CR45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3892\/or.2012.1865","volume":"28","author":"B Chang","year":"2012","unstructured":"Chang B, Kim J, Jeong D, Jeong Y, Jeon S, Jung SI, Yang Y, Kim KI, Lim JS, Kim C, Lee MS: Klotho inhibits the capacity of cell migration and invasion in cervical cancer. Oncol Rep. 2012, 28: 1022-1028.","journal-title":"Oncol Rep"},{"key":"103_CR46","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1016\/j.ejca.2008.08.004","volume":"44","author":"CL Huang","year":"2008","unstructured":"Huang CL, Liu D, Ishikawa S, Nakashima T, Nakashima N, Yokomise H, Kadota K, Ueno M: Wnt1 overexpression promotes tumour progression in non-small cell lung cancer. Eur J Cancer. 2008, 44: 2680-2688. 10.1016\/j.ejca.2008.08.004.","journal-title":"Eur J Cancer"},{"key":"103_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ejca.2004.11.005","volume":"41","author":"H Doucas","year":"2005","unstructured":"Doucas H, Garcea G, Neal CP, Manson MM, Berry DP: Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer. 2005, 41: 365-379. 10.1016\/j.ejca.2004.11.005.","journal-title":"Eur J Cancer"},{"key":"103_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000066755","volume":"66","author":"FT Kolligs","year":"2002","unstructured":"Kolligs FT, Bommer G, Goke B: Wnt\/beta-catenin\/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion. 2002, 66: 131-144. 10.1159\/000066755.","journal-title":"Digestion"},{"key":"103_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002, 2: 442-454. 10.1038\/nrc822.","journal-title":"Nat Rev Cancer"},{"key":"103_CR50","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/sj.bjc.6603193","volume":"94","author":"M Shioiri","year":"2006","unstructured":"Shioiri M, Shida T, Koda K, Oda K, Seike K, Nishimura M, Takano S, Miyazaki M: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer. 2006, 94: 1816-1822. 10.1038\/sj.bjc.6603193.","journal-title":"Br J Cancer"},{"key":"103_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1756-9966-32-62","volume":"32","author":"M Tsubaki","year":"2013","unstructured":"Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S: Activation of NF-kappaB by the RANKL\/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. J Exp Clin Cancer Res. 2013, 32: 62-10.1186\/1756-9966-32-62.","journal-title":"J Exp Clin Cancer Res"},{"key":"103_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1756-9966-31-29","volume":"31","author":"L Zhu","year":"2012","unstructured":"Zhu L, Qin H, Li PY, Xu SN, Pang HF, Zhao HZ, Li DM, Zhao Q: Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3. J Exp Clin Cancer Res. 2012, 31: 29-10.1186\/1756-9966-31-29.","journal-title":"J Exp Clin Cancer Res"},{"key":"103_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13046-014-0062-0","volume":"33","author":"S Kaufhold","year":"2014","unstructured":"Kaufhold S, Bonavida B: Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res. 2014, 33: 62-10.1186\/s13046-014-0062-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"103_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1756-9966-29-109","volume":"29","author":"M Li","year":"2010","unstructured":"Li M, Zhang B, Sun B, Wang X, Ban X, Sun T, Liu Z, Zhao X: A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis. J Exp Clin Cancer Res. 2010, 29: 109-10.1186\/1756-9966-29-109.","journal-title":"J Exp Clin Cancer Res"},{"key":"103_CR55","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1091\/mbc.E13-07-0360","volume":"25","author":"T Sobolik","year":"2014","unstructured":"Sobolik T, Su YJ, Wells S, Ayers GD, Cook RS, Richmond A: CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways. Mol Biol Cell. 2014, 25: 566-582. 10.1091\/mbc.E13-07-0360.","journal-title":"Mol Biol Cell"},{"key":"103_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1741-7015-10-85","volume":"10","author":"SS Zhang","year":"2012","unstructured":"Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ, Wang H, Wang Y, Li R, Yang Y, Zhao X, Xu XD, Yu ED, Rui YC, Liu HJ, Zhang L, Wei LX: CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med. 2012, 10: 85-10.1186\/1741-7015-10-85.","journal-title":"BMC Med"},{"key":"103_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2559.2011.04139.x","volume":"61","author":"MF Fanelli","year":"2012","unstructured":"Fanelli MF, Chinen LT, Begnami MD, Costa WL, Fregnami JH, Soares FA, Montagnini AL: The influence of transforming growth factor-alpha, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Histopathology. 2012, 61: 153-161. 10.1111\/j.1365-2559.2011.04139.x.","journal-title":"Histopathology"},{"key":"103_CR58","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.cellsig.2009.06.006","volume":"21","author":"E Bertran","year":"2009","unstructured":"Bertran E, Caja L, Navarro E, Sancho P, Mainez J, Murillo MM, Vinyals A, Fabra A, Fabregat I: Role of CXCR4\/SDF-1 alpha in the migratory phenotype of hepatoma cells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-beta. Cell Signal. 2009, 21: 1595-1606. 10.1016\/j.cellsig.2009.06.006.","journal-title":"Cell Signal"},{"key":"103_CR59","first-page":"993","volume":"19","author":"M Taki","year":"2008","unstructured":"Taki M, Higashikawa K, Yoneda S, Ono S, Shigeishi H, Nagayama M, Kamata N: Up-regulation of stromal cell-derived factor-1alpha and its receptor CXCR4 expression accompanied with epithelial-mesenchymal transition in human oral squamous cell carcinoma. Oncol Rep. 2008, 19: 993-998.","journal-title":"Oncol Rep"},{"key":"103_CR60","first-page":"1133","volume":"29","author":"T Onoue","year":"2006","unstructured":"Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H, Sato M: Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1\/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol. 2006, 29: 1133-1138.","journal-title":"Int J Oncol"},{"key":"103_CR61","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","volume":"119","author":"GL Uy","year":"2012","unstructured":"Uy GL, Rettig MP, Motabi IH, McFarland K, Trinkaus KM, Hladnik LM, Kulkarni S, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Vij R, Westervelt P, DiPersio JF: A phase 1\/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood. 2012, 119: 3917-3924. 10.1182\/blood-2011-10-383406.","journal-title":"Blood"},{"issue":"13","key":"103_CR62","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1158\/1078-0432.CCR-13-2686","volume":"20","author":"MD Galsky","year":"2014","unstructured":"Galsky MD, Vogelzang NJ, Conkling P, Raddad E, Polzer J, Roberson S, Stille JR, Saleh M, Thornton D: A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer. Clin Cancer Res. 2014, 20 (13): 3581-3588. 10.1158\/1078-0432.CCR-13-2686.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-014-0103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-014-0103-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-014-0103-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-014-0103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:43:11Z","timestamp":1630564991000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-014-0103-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1186\/s13046-014-0103-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"16 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"103"}}